نتائج البحث

Changes in polyunsaturated fatty acids are linked to metabolic syndrome in children with steroid-sensitive nephrotic syndrome-a clinical observation.

• Authors : Li PL; Kunming Children's Hospital & Children's Hospital Affiliated to Kunming Medical University, Kunming Medical University, Kunming, P.R. China.; Department of Pulmonary and Critical Care Medicine, Kunming Children's Hospital, Kunming Medical University, Kunming, P.R. China.

Subjects: Metabolic Syndrome*/Metabolic Syndrome*/Metabolic Syndrome*/blood ; Metabolic Syndrome*/Metabolic Syndrome*/Metabolic Syndrome*/complications ; Nephrotic Syndrome*/Nephrotic Syndrome*/Nephrotic Syndrome*/blood

• Source: Lipids in health and disease [Lipids Health Dis] 2025 Mar 27; Vol. 24 (1), pp. 115. Date of Electronic Publication: 2025 Mar 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101147696 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-511X

تفاصيل العنوان

The association between lipid profile, oxidized LDL and the components of metabolic syndrome with serum mineral status and kidney function in individuals with obesity.

• Authors : Ardekani AM; Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Science, & Physiology Research Center, Kerman University of Medical Sciences, Kerman, Iran.; Nava ZH

Subjects: Metabolic Syndrome*; Adult ; Humans

• Source: BMC research notes [BMC Res Notes] 2023 Sep 05; Vol. 16 (1), pp. 196. Date of Electronic Publication: 2023 Sep 05.Publisher: Biomed Central Country of Publication: England NLM ID: 101462768 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-0500

تفاصيل العنوان

Association between metabolic score for insulin resistance (METS-IR) and hypertension: a cross-sectional study based on NHANES 2007-2018.

• Authors : Guo Z; Department of Cardiovascular Medicine, The First Hospital of Jilin University, Changchun, 130021, China.; Guo X

Subjects: Hypertension*/Hypertension*/Hypertension*/blood ; Hypertension*/Hypertension*/Hypertension*/epidemiology ; Hypertension*/Hypertension*/Hypertension*/physiopathology

• Source: Lipids in health and disease [Lipids Health Dis] 2025 Feb 21; Vol. 24 (1), pp. 64. Date of Electronic Publication: 2025 Feb 21.Publisher: BioMed Central Country of Publication: England NLM ID: 101147696 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-511X

تفاصيل العنوان

LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering (SOLVE-LDL-C)

• Authors : Novartis; Pam Taub, MD, Professor of Medicine, Directior of Preventative Cardiology

• Source: Study of Optimal LDL-C Value Enhancement With Inclisiran in Patients With Multiple Comorbidities in Which There Are Drug-Drug Interactions Limiting

تفاصيل العنوان

Markers of Metabolic Abnormalities in Vitiligo Patients.

• Authors : Papaccio F; Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy.; Ottaviani M

Subjects: Vitiligo*/Vitiligo*/Vitiligo*/blood ; Vitiligo*/Vitiligo*/Vitiligo*/metabolism ; Biomarkers*/Biomarkers*/Biomarkers*/blood

• Source: International journal of molecular sciences [Int J Mol Sci] 2024 Sep 23; Vol. 25 (18). Date of Electronic Publication: 2024 Sep 23.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

Increased Adipose Tissue Expression of IL-23 Associates with Inflammatory Markers in People with High LDL Cholesterol.

• Authors : Kochumon S; Department of Immunology & Microbiology, Dasman Diabetes Institute, Dasman 15462, Kuwait.; Hasan A

Subjects: Hyperlipidemias*/Hyperlipidemias*/Hyperlipidemias*/metabolism ; Metabolic Syndrome*/Metabolic Syndrome*/Metabolic Syndrome*/metabolism; Interleukin-23 Subunit p19/Interleukin-23 Subunit p19/Interleukin-23 Subunit p19/*metabolism

• Source: Cells [Cells] 2022 Sep 29; Vol. 11 (19). Date of Electronic Publication: 2022 Sep 29.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

تفاصيل العنوان

Loss of GPR40 in LDL receptor-deficient mice exacerbates high-fat diet-induced hyperlipidemia and nonalcoholic steatohepatitis.

• Authors : Lu Z; Division of Endocrinology, Diabetes and Metabolic Diseases, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.; Li Y

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism ; Hyperlipidemias*/Hyperlipidemias*/Hyperlipidemias*/complications ; Hyperlipidemias*/Hyperlipidemias*/Hyperlipidemias*/genetics

• Source: PloS one [PLoS One] 2022 Nov 04; Vol. 17 (11), pp. e0277251. Date of Electronic Publication: 2022 Nov 04 (Print Publication: 2022).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

The Effectiveness and Safety of a Nutraceutical Combination in Overweight Patients with Metabolic Syndrome.

• Authors : Ricottini L; Sinergheia Clinical Center, 00192 Rome, Italy.; Basciani S

Subjects: Dietary Supplements* ; Metabolic Syndrome*/Metabolic Syndrome*/Metabolic Syndrome*/drug therapy ; Metabolic Syndrome*/Metabolic Syndrome*/Metabolic Syndrome*/blood

• Source: Nutrients [Nutrients] 2024 Nov 21; Vol. 16 (23). Date of Electronic Publication: 2024 Nov 21.Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Effects of synbiotic supplementation on the components of metabolic syndrome in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.

• Authors : Basafa-Roodi P; Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.; Jazayeri S

Subjects: Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Schizophrenia*/Schizophrenia*/Schizophrenia*/complications ; Metabolic Syndrome*

• Source: BMC psychiatry [BMC Psychiatry] 2024 Oct 09; Vol. 24 (1), pp. 669. Date of Electronic Publication: 2024 Oct 09.Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X

تفاصيل العنوان

Serum Levels of Adiponectin Are Strongly Associated with Lipoprotein Subclasses in Healthy Volunteers but Not in Patients with Metabolic Syndrome.

• Authors : Klobučar I; Department of Cardiology, Sisters of Charity University Hospital Centre, 10000 Zagreb, Croatia.; Habisch H

Subjects: Adiponectin*/Adiponectin*/Adiponectin*/blood ; Lipoproteins*/Lipoproteins*/Lipoproteins*/blood ; Metabolic Syndrome*/Metabolic Syndrome*/Metabolic Syndrome*/blood

• Source: International journal of molecular sciences [Int J Mol Sci] 2024 May 06; Vol. 25 (9). Date of Electronic Publication: 2024 May 06.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان